Skip to main content

The context you need, when you need it

When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our own.

We rely on readers like you to fund our journalism. Will you support our work and become a Vox Member today?

Join now

LinkedIn Shares Slump on Lowered Guidance

The company still beat analysts’ expectations for the quarter.

Ken Wolter / Shutterstock

LinkedIn again beat analysts’ expectations with its fourth-quarter earnings report, yet shares fell on Thursday afternoon as the company lowered its financial outlook for the coming year.

LinkedIn expects revenue of around $460 million over the first quarter of 2014, down from the estimates of $470 million. And for the full year of 2014, LinkedIn expects revenue of $2.02 billion to $2.05 billion, also lower than the expected $2.165 billion.

Shares tumbled about 12 percent in after-hours trading, hovering around $197.23.

Something worth noting: LinkedIn has a history of conservative guidance. This story isn’t anything new.

Part of that comes from increased reinvestment into its business. “When you talk about conservatism in guidance, we try to take a best stab at what the business will project,” CFO Steve Sordello said on a conference call with analysts on Thursday. “There’s a number of very heavy investments in 2014, and we’re looking at it from a very long-term perspective.”

That includes investing in moving the company’s business into China, increasing headcount and building three major data centers over the next two years, among other expenditures.

The financials came alongside of LinkedIn’s largest acquisition to date, as the company announced it will purchase Bright, a data-driven job-seeking company based in San Francisco.

“Ultimately, our members won’t need to find jobs, the relevant jobs will find them,” CEO Jeff Weiner said on the call.

That, too, affected LinkedIn’s guidance numbers, as the Bright acquisition won’t actually yield any revenue in 2014.

Investor wariness over the guidance prevailed, despite a slim earnings beat for the company in the fourth quarter. LinkedIn reported earnings per share of 39 cents on revenue of $447.2 million. That edges out analysts’ expectations of EPS of 38 cents on revenue of $437.84 million.

As always, the bulk of the company’s revenue came from the Talent Solutions group, raking in $245.6 million, a year-over-year increase of 53 percent. The rest came from LinkedIn’s marketing group, at $113.5 million, and the premium subscriptions group, at $88.1 million.

One last high note: The company hit the 277 million user mark last quarter.

This article originally appeared on Recode.net.

More in Technology

Podcasts
Are humanoid robots all hype?Are humanoid robots all hype?
Podcast
Podcasts

AI is making them better — but they’re not going to be doing your chores anytime soon.

By Avishay Artsy and Sean Rameswaram
Future Perfect
The old tech that could help stop the next airborne pandemicThe old tech that could help stop the next airborne pandemic
Future Perfect

Glycol vapors, explained.

By Shayna Korol
Future Perfect
Elon Musk could lose his case against OpenAI — and still get what he wantsElon Musk could lose his case against OpenAI — and still get what he wants
Future Perfect

It’s not about who wins. It’s about the dirty laundry you air along the way.

By Sara Herschander
Life
Why banning kids from AI isn’t the answerWhy banning kids from AI isn’t the answer
Life

What kids really need in the age of artificial intelligence.

By Anna North
Culture
Anthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque messAnthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque mess
Culture

“Your AI monster ate all our work. Now you’re trying to pay us off with this piece of garbage that doesn’t work.”

By Constance Grady
Future Perfect
Some deaf children are hearing again because of a new gene therapySome deaf children are hearing again because of a new gene therapy
Future Perfect

A medical field that almost died is quietly fixing one disease at a time.

By Bryan Walsh